Gross Profit
Becton, Dickinson and Company Gross Profit decreased by 10.7% to $2.15B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $1.86B to $2.15B. Over 4 years (FY 2021 to FY 2025), Gross Profit shows relatively stable performance with a 1.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests improved manufacturing efficiency, better pricing power, or a favorable shift in product mix toward higher-margin medical devices, while a decrease may indicate rising raw material costs or pricing pressure.
Detailed definition
Gross profit represents the residual profit after deducting the direct costs associated with manufacturing and distribut...
Peer comparison
Peer medical technology companies typically maintain high gross margins due to the specialized nature of their products, with variations driven by the specific mix of high-volume disposables versus high-tech diagnostic systems.
gross_profitHistorical Data
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.96B | $2.09B | $2.22B | $2.11B | $2.07B | $2.08B | $2.13B | $2.24B | $2.10B | $1.70B | $2.03B | $2.30B | $2.31B | $2.49B | $2.24B | $1.86B | $2.63B | $2.80B | $2.41B | $2.15B |
| QoQ Change | — | +6.6% | +6.4% | -4.8% | -2.2% | +0.5% | +2.7% | +4.8% | -6.0% | -19.0% | +19.2% | +13.7% | +0.1% | +7.8% | -10.1% | -16.7% | +41.5% | +6.3% | -13.9% | -10.7% |
| YoY Change | — | — | — | — | +5.6% | -0.5% | -3.9% | +5.8% | +1.6% | -18.1% | -5.0% | +3.1% | +9.9% | +46.2% | +10.3% | -19.2% | +14.2% | +12.5% | +7.9% | +15.7% |
Gross Profit at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's gross profit?
- Becton, Dickinson and Company (BDX) reported gross profit of $2.15B in Q1 2026.
- How has Becton, Dickinson and Company's gross profit changed year-over-year?
- Becton, Dickinson and Company's gross profit increased by 15.7% year-over-year, from $1.86B to $2.15B.
- What is the long-term trend for Becton, Dickinson and Company's gross profit?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's gross profit has grown at a 1.4% compound annual growth rate (CAGR), from $9.02B to $9.53B.
- What does gross profit mean?
- The total revenue remaining after subtracting the direct costs of producing and delivering the company's medical products.